Molecular modeling and description of a newly characterized activating mutation of the EGFR gene in non-small cell lung cancer
<p>Abstract</p> <p>Lung cancer is the leading cause of death among malignant diseases in humans worldwide. In the last decade development of new targeted drugs for the treatment of non-small cell lung cancer proved to be a promising approach to prolong the otherwise very poor progn...
Main Authors: | Otto Claudia, Csanadi Agnes, Fisch Paul, Werner Martin, Kayser Gian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | Diagnostic Pathology |
Online Access: | http://www.diagnosticpathology.org/content/7/1/146 |
Similar Items
-
Simultaneous multi-antibody staining in non-small cell lung cancer strengthens diagnostic accuracy especially in small tissue samples.
by: Gian Kayser, et al.
Published: (2013-01-01) -
Molecular Imaging in vivo Detection of EGFR Mutations in Non-small Cell Lung Cancer
by: Danjing LUO, et al.
Published: (2017-06-01) -
Presence of PCR artifacts in Sanger sequencing in Formalin-fixed paraffin-embedded (FFPE) tissue – experience in a collective of 990 advanced NSCLC
by: Claudia Kayser, et al.
Published: (2016-12-01) -
EGFR Mutations and Lung Cancer.
Published: (2005-11-01) -
Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients
by: Syahruddin E, et al.
Published: (2018-03-01)